Addition of Docetaxel to Androgen Receptor Axis–targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis
Soumyajit Roy, Rashid K. Sayyid, Fred Saad, Yilun Sun, Katherine Lajkosz, Michael Ong, Zachary Klaassen, Shawn Malone, Daniel E. Spratt, Christopher J.D. Wallis, Scott C. Morgan
Topics & Concepts
DocetaxelAndrogen deprivation therapyMedicineProstate cancerOncologyInternal medicineHazard ratioClinical endpointRandomized controlled trialConfidence intervalAndrogen receptorMeta-analysisCancerProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and Metabolism